investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia
Markus Muschen
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Warren Alexander
Walter and Eliza Hall Institute of Medical Research
Melbourne, Australia
Markus Muschen
University of California, San Francisco
San Francisco, United States
Related projects
Rong Li
Regulation of Hormone Production by Matrix Proteins
Breast
Ann Richmond
Chemokine Signals in the Premetastatic Niche Inhibit Metastasis
Breast
Dan Landau
The role of epigenetic heterogeneity in CLL evolution
Leukaemia
Michael Ryan Corces-Zimmerman
Functional significance of Pre-Leukemic HSC in Human Acute Myeloid Leukemia
Leukaemia
David A Scheinberg
Mechanisms of action of a TCR-like antibody to WT1
Leukaemia
Ravi Bhatia
Microenvironmental Regulation of Leukemia Stem Cells
Leukaemia
Hematology and hematologic malignancies
Robert Stanley
Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms
Leukaemia
Hematology and hematologic malignancies
Joseph H Antin
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
Leukaemia
Douglas R Green
RIPK-Dependent Necrosis in Development and Cancer
Trachea, bronchus and lung